Why Barclays PLC’s Fine Could Represent A Buying Opportunity!

Here’s why Barclays PLC (LON: BARC) could be well worth buying after its recent fines.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Barclays

Life as an investor in Barclays (LSE: BARC) (NYSE: BCS.US) continues to be a rather difficult existence. As well as shares in the bank having performed dismally during the course of 2014, with them being down 16% since the turn of the year, Barclays continues to be fined by various regulators.

The latest of these are fines by the UK’s FCA for client asset breaches (£38 million) and £9 million for lax internal compliance procedures in the wake of the Lehman Brothers takeover in 2008, levied by the US SEC.

Weak Sentiment

While neither fine is particularly large when compared to Barclays’ pre-tax profit of £5.8 billion that is due to be recorded in the current financial year, they mean more bad headlines for the bank. In turn, this weakens investor sentiment and causes the share price to remain depressed. Indeed, with Barclays still having the potential for more fines, including allegations of fraud in its dark pool trading system, sentiment could remain weak for a little while yet.

Buying Opportunity

However, such weak sentiment presents a buying opportunity for Foolish investors. That’s because, while Barclays is still feeling the effects of what appear to be lax internal controls under previous management, the bank continues to make excellent progress towards becoming leaner, more efficient and, ultimately, more profitable.

Growth Potential

For example, Barclays is forecast to increase earnings per share (EPS) by a whopping 27% in the current year, followed by further growth of 28% next year. This means that shares in the bank currently trade on a price to earnings (P/E) ratio of 10.7 and a price to earnings growth (PEG) ratio of only 0.4. Together, these figures show that Barclays offers very strong growth at an incredibly attractive price.

Looking Ahead

Clearly, Barclays is unlikely to see sentiment pick up to a significant extent until it leaves behind legacy issues such as the fines that were announced this week. In the meantime, though, a smaller, less risky and hugely more profitable bank is being built; as shown by the strong earnings growth forecasts for the next couple of years. This provides investors with the chance to buy in to Barclays at a very low price and, as a result, it could prove to be a winning investment over the medium term.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Peter Stephens owns shares of Barclays.

More on Investing Articles

Number three written on white chat bubble on blue background
Investing Articles

Just released: the 3 best growth-focused stocks to consider buying in May [PREMIUM PICKS]

Our goal here is to highlight some of our past recommendations that we think are of particular interest today, due…

Read more »

Portrait of elderly man wearing white denim shirt and glasses looking up with hand on chin. Thoughtful senior entrepreneur, studio shot against grey background.
Investing Articles

With £1,000 to invest, should I buy growth stocks or income shares?

Dividend shares are a great source of passive income, but how close to retirement, should investors think about shifting away…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

Warren Buffett should buy this flagging FTSE 100 firm!

After giving $50bn to charity, Warren Buffett still has a $132bn fortune. Also, his company has $168bn to spend, so…

Read more »

Middle-aged white man wearing glasses, staring into space over the top of his laptop in a coffee shop
Investing For Beginners

I wish I’d known about this lucrative style of stock market investing 20 years ago

Research has shown that over the long term, this style of investing can generate returns in excess of those provided…

Read more »

Woman using laptop and working from home
Investing Articles

Is this growing UK fintech one of the best shares to buy now?

With revenues growing at 24% and income growing at 36%, Wise looks like one of the best shares to buy…

Read more »

Dividend Shares

Are Aviva shares one of the UK’s best investments today?

UK investors have been piling into Aviva shares recently. However, Edward Sheldon's wondering if he could get bigger returns elsewhere.

Read more »

Older couple walking in park
Investing Articles

10.2% dividend yield! 2 value shares to consider for a £1,530 passive income

Royston Wild explains why investing in these value shares could provide investors with significant passive income for years to come.

Read more »

man in shirt using computer and smiling while working in the office
Investing Articles

Nvidia and a FTSE 100 fund own a 10% stake in this $8 artificial intelligence (AI) stock

Ben McPoland explores Recursion Pharmaceuticals (NASDAQ:RXRX), an up-and-coming AI firm held by Cathie Wood, Nvidia and one FTSE 100 trust.

Read more »